ADAPT Study
Public Health Sciences, Cancer PreventionThe ADAPT study is interested in learning why weight loss stops and if body and brain changes can predict halted weight loss, known as an involuntary weight loss plateau. The study lasts about 18 months and includes in-person visits at the University of Washington South Lake Union campus and Fred Hutch.
Advanced Colorectal Cancer of Serrated Subtype (ACCESS) Study
Public Health Sciences, Cancer PreventionResearchers are studying a subtype of colorectal cancer (CRC) that develops via the serrated pathway with a goal of determining future prevention strategies and advancing treatment for CRC.
Funding Agency: National Institutes of Health
Contact: Rachel Malen, rmalen@fredhutch.org
Ancillary Cost-Effectiveness Analysis
Public Health Sciences, Cancer PreventionResearchers are determining the cost-effectiveness of cord blood vs. haplo matched relatives using clinical information from the Bone Marrow Transplant (BMT) Clinical Trials Network (CTN) and insurance claims data.
Funding Agency: National Institutes of Health
Contact: Jordan Steelquist, jsteelq@fredhutch.org
Bacterial Correlates of Colorectal Cancer Subtypes and Survival
Public Health Sciences, EpidemiologyScientists identify differences in the bacterial community in tumors for patients with etiologically-distinct subgroups of colorectal cancer, and how those differences relate to survival.
Funding Agency: National Cancer Institute
Contact: Amanda Phipps, aphipps@fredhutch.org
Bacterial Vaginosis Study
Vaccine and Infectious Disease Division, Infectious Disease SciencesFred Hutchinson Cancer Center is conducting a study to learm more to improve the speed and accuracy of bacterial vaginosis diagnosis.
Contact: Sue Bartlett, sbartlett@fredhutch.org
Breast Cancer Initiative 2.5
Breast Cancer Initiative 2.5 is uniting the global breast cancer community behind a common goal to make breast health a global priority and reduce disparities in breast cancer outcomes for 2.5 million women by 2025.
Carotene and Retinol Efficacy Trial (CARET)
- Marian Neuhouser, PhD, RD
- Matty Triplette, MD, MPH
- Mark Thornquist, PhD
- Gary Goodman, MD
- Chu Chen, PhD
Researchers tested the efficacy and safety of beta-carotene and retinyl palmitate in people at high risk for lung cancer in a randomized, double-blind, placebo-controlled trial. Active follow-up of trial. participants ended on June of 2005; however, the program continues to support the extensive biological repository and ancillary studies that use CARET samples and data.
Funding Agency: National Cancer Institute
Contact: Becky Harbine, bharbine@fredhutch.org
Case-control study of ovarian cancer (DOVE)
- Mary Anne Rossing, Ph.D., D.V.M.
- Holly Harris, Sc.D., M.P.H.
Using two ovarian cancer case-control studies, scientists are trying to determine why some women develop ovarian tumors and others do not.
Funding Agency: National Cancer Institute
Contact: Holly Harris, hharris@fredhutch.org
Clinical and Economic Value of Next Generation Sequencing-Based Diagnostic Testing in Cancer Care
Public Health Sciences, Cancer PreventionResearchers are developing a decision model designed to evaluate the cost effectiveness of multiplex NGS testing vs. usual care. They plan to pair the decision model with information theory to identify the most efficient and impactful study designs.
Funding Agency: Personalized Medicine Coalition
Contact: Jordan Steelquist, jsteelq@fredhutch.org
Collaboration for a Healthy Community (Together We STRIDE)
Public Health Sciences, Cancer PreventionThe goal of the project is to build and enhance community capacity and infrastructure on childhood obesity initiatives in the Lower Yakima Valley, Washington.
Funding Agency: National Institute on Minority Health and Health Disparities
Contact: Sonia Bishop, sbishop@fredhutch.org